The deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having "substantial ...
Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with Sanofi for its COVID-19 vaccine in ...
Novavax (NVAX) stock surged after reaching a licensing agreement with Sanofi (SNY) for its COVID-19 vaccine and Matrix-M adjuvant. Read more here.
Shah Capital Management has withdrawn a proxy campaign against the re-election of directors at vaccines firm Novavax in the ...
A Novavax shareholder that had been waging a campaign to oust three board members at the Gaithersburg company has now ...
The vaccine maker's recovery story is looking brighter.
Novavax ( NVAX -9.65%) has been a highly volatile stock in recent years, and that volatility is on full display again this ...
Novavax's updated vaccine targets a variant called JN.1, which is in line with European recommendations. The European Union's ...
Aventis S.A. ADR (SNY-Q) from The Globe and Mail including charting and trades.
The COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller ...
Novavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID-19-influenza combination ...
Novavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company. This withdrawal is in ...